DALLAS, January 20, 2011 /PRNewswire/ -- The 'Top 10 Drug Delivery Technologies Market (2010 - 2015)' analyzes the drug delivery technologies market by the top 10 drug delivery technologies and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia and ROW.
Browse 75 market data tables and in-depth TOC on Top 10 Drug Delivery Technologies Market: Global Forecast.
(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)
Early buyers will receive 10% customization of reports.
The rising demand for effective delivery of novel biopharmaceuticals is driving the growth of the global top 10 drug delivery technologies market. Further, drug patent expiration is also boosting market growth. The top 10 drug delivery technologies market is expected to grow from 77 billion in 2009 to 156 billion in 2015, at an estimated CAGR of 17% from 2010 to 2015. Prominent industry participants include Elan, Biovail, Alkermes & Nektar.
Each sub-segment of the top 10 drug delivery technologies market is calculated for the four geographies of North America, Europe, Asia, and Rest of the World (ROW). North America is leading the market in 2009 with a 41% revenue share followed by European market contributing to 30% in 2009 which is expected to become the largest market in 2015 at $49.5 billion, growing at a CAGR of 18.7% during 2010 - 2015.
Controlled release technology market account for the largest share with $20 billion revenue in 2010 and is expected to grow at a CAGR of 10.2% during 2010-2015
Unconventional modes of drug delivery such as pulmonary, nasal and transdermal are gaining a lot of popularity especially in chronic disease conditions such as diabetes, hypertension, CNS and cancer. Nanotechnology advances have led to the development of innovative drug delivery systems.
Drug delivery technologies are revenue boosters for the pharmaceutical industry as they enhance drug life cycle in the market by extending patent rights, adding a competitive edge to the drug by enhancing their safety and efficacy. Further, expansion of the applications of non conventional modes of drug delivery such as pulmonary, nasal and transdermal in disease conditions other than respiratory and skin, especially in chronic disease conditions such as diabetes, CNS are also boosting the market. In addition, innovations such as microneedle transdermal patches and novel intelligent inhalers are also adding to the market growth. However, increase in drug failures, pricing pressure, reimbursement issues and third party dependence are challenges for the market.
Currently, market players are focusing in the development and commercialization of new drugs through agreements and collaborations which therefore accounted for the highest share of the total competitive developments in the global top 10 drug delivery technologies market from 2007 to June 2010.
Scope of the report
The report analyzes Top 10 drug delivery technologies market including their market sizes and forecasts. It also provides a detailed analysis of the market trends, factors influencing market growth and in-depth geographic analyses in North America, Europe, Asia, and Rest of the World (ROW) markets. The report draws competitive landscape, comparative analysis of the technological and marketing strategies the key players are adopting in order to gain an edge over the their competitors
This research report categorizes the top 10 drug delivery technologies on the basis of their growth, therapeutic areas, patents, and industry focus of the following sub categories:
- Controlled release technologies - Targeted delivery - Inhaler device technology - Encapsulation technology - Topical formulations - Injectable device technology - Trandermal patch - Implantable drug delivery technology - Liposomal drug delivery - PEGlyation technology
- Manufacturers, suppliers, and dealers of drug delivery technologies - Pharmaceutical and biotech companies - Healthcare providers - Potential investors in the drug delivery technologies market
MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website http://www.marketsandmarkets.com
Mr. Rohan 7557 Rambler Road, Suite 727, Dallas, TX 75231 Tel: +1-888-600-6441 Email: firstname.lastname@example.org http://www.marketsandmarkets.com http://marketsandmarkets.blogspot.com